{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:25:29Z","timestamp":1785291929529,"version":"3.55.0"},"reference-count":229,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41581-026-01067-z","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:02:36Z","timestamp":1774288956000},"page":"422-437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The endothelium response to kidney injury"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8028-8205","authenticated-orcid":false,"given":"Kyle H.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1842-1343","authenticated-orcid":false,"given":"Arin L.","family":"Melkonian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4276-5186","authenticated-orcid":false,"given":"Anupam","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"1067_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41581-018-0098-z","volume":"15","author":"N Jourde-Chiche","year":"2019","unstructured":"Jourde-Chiche, N. et al. Endothelium structure and function in kidney health and disease. Nat. Rev. Nephrol. 15, 87\u2013108 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"1067_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41581-021-00411-9","volume":"17","author":"SJ Dumas","year":"2021","unstructured":"Dumas, S. J. et al. Phenotypic diversity and metabolic specialization of renal endothelial cells. Nat. Rev. Nephrol. 17, 441\u2013464 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"1067_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis, A. et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat. Rev. Nephrol. 20, 473\u2013485 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"1067_CR4","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1186\/1755-1536-5-S1-S15","volume":"5","author":"D Guerrot","year":"2012","unstructured":"Guerrot, D. et al. Progression of renal fibrosis: the underestimated role of endothelial alterations. Fibrogenesis Tissue Repair. 5, S15 (2012).","journal-title":"Fibrogenesis Tissue Repair."},{"key":"1067_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082359","volume":"9","author":"S Roumeliotis","year":"2020","unstructured":"Roumeliotis, S., Mallamaci, F. & Zoccali, C. Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update. J. Clin. Med. 9, 2359 (2020).","journal-title":"J. Clin. Med."},{"key":"1067_CR6","doi-asserted-by":"publisher","first-page":"F309","DOI":"10.1152\/ajprenal.00371.2021","volume":"322","author":"JC Oates","year":"2022","unstructured":"Oates, J. C., Russell, D. L. & Van Beusecum, J. P. Endothelial cells: potential novel regulators of renal inflammation. Am. J. Physiol. Ren. Physiol 322, F309\u2013F321 (2022).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clim.2008.08.016","volume":"130","author":"HR Jang","year":"2009","unstructured":"Jang, H. R. & Rabb, H. The innate immune response in ischemic acute kidney injury. Clin. Immunol. 130, 41\u201350 (2009).","journal-title":"Clin. Immunol."},{"key":"1067_CR8","doi-asserted-by":"publisher","first-page":"R508","DOI":"10.1152\/ajpregu.00340.2020","volume":"320","author":"KH Moore","year":"2021","unstructured":"Moore, K. H., Murphy, H. A. & George, E. M. The glycocalyx: a central regulator of vascular function. Am. J. Physiol. Regul. Integr. Comp. Physiol 320, R508\u2013R518 (2021).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol"},{"key":"1067_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/sj.ki.5002312","volume":"72","author":"DP Basile","year":"2007","unstructured":"Basile, D. P. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int. 72, 151\u2013156 (2007).","journal-title":"Kidney Int."},{"key":"1067_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneph.2013.282","volume":"10","author":"O Rewa","year":"2014","unstructured":"Rewa, O. & Bagshaw, S. M. Acute kidney injury-epidemiology, outcomes and economics. Nat. Rev. Nephrol. 10, 193\u2013207 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"1067_CR11","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/ki.1991.138","volume":"39","author":"JD Conger","year":"1991","unstructured":"Conger, J. D., Robinette, J. B. & Hammond, W. S. Differences in vascular reactivity in models of ischemic acute renal failure. Kidney Int. 39, 1087\u20131097 (1991).","journal-title":"Kidney Int."},{"key":"1067_CR12","doi-asserted-by":"publisher","first-page":"F25","DOI":"10.1152\/ajprenal.90531.2008","volume":"296","author":"O Kwon","year":"2009","unstructured":"Kwon, O., Hong, S. M. & Ramesh, G. Diminished NO generation by injured endothelium and loss of macula densa nNOS may contribute to sustained acute kidney injury after ischemia-reperfusion. Am. J. Physiol. Ren. Physiol 296, F25\u2013F33 (2009).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1172\/JCI113628","volume":"82","author":"JD Conger","year":"1988","unstructured":"Conger, J. D., Robinette, J. B. & Schrier, R. W. Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J. Clin. Invest. 82, 532\u2013537 (1988).","journal-title":"J. Clin. Invest."},{"key":"1067_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1046\/j.1523-1755.2003.00063.x","volume":"64","author":"R Schneider","year":"2003","unstructured":"Schneider, R. et al. L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int. 64, 216\u2013225 (2003).","journal-title":"Kidney Int."},{"key":"1067_CR15","first-page":"25","volume":"4","author":"J Conger","year":"1997","unstructured":"Conger, J. Hemodynamic factors in acute renal failure. Adv. Ren. Replace. Ther. 4, 25\u201337 (1997).","journal-title":"Adv. Ren. Replace. Ther."},{"key":"1067_CR16","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1172\/JCI45161","volume":"121","author":"JV Bonventre","year":"2011","unstructured":"Bonventre, J. V. & Yang, L. Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 121, 4210\u20134221 (2011).","journal-title":"J. Clin. Invest."},{"key":"1067_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/602149","volume":"2014","author":"HS Jang","year":"2014","unstructured":"Jang, H. S., Kim, J. I., Kim, J., Park, J. W. & Park, K. M. Angiotensin II removes kidney resistance conferred by ischemic preconditioning. Biomed. Res. Int. 2014, 602149 (2014).","journal-title":"Biomed. Res. Int."},{"key":"1067_CR18","first-page":"23","volume":"118","author":"RC Blantz","year":"2007","unstructured":"Blantz, R. C., Deng, A., Miracle, C. M. & Thomson, S. C. Regulation of kidney function and metabolism: a question of supply and demand. Trans. Am. Clin. Climatol. Assoc. 118, 23\u201343 (2007).","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"1067_CR19","doi-asserted-by":"publisher","first-page":"F721","DOI":"10.1152\/ajprenal.00546.2010","volume":"300","author":"DP Basile","year":"2011","unstructured":"Basile, D. P. et al. Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am. J. Physiol. Ren. Physiol 300, F721\u2013F733 (2011).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR20","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1681\/ASN.2008050513","volume":"19","author":"EM Zeisberg","year":"2008","unstructured":"Zeisberg, E. M., Potenta, S. E., Sugimoto, H., Zeisberg, M. & Kalluri, R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrol. 19, 2282\u20132287 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1067_CR21","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/j.1440-1681.2006.04476.x","volume":"33","author":"JT Norman","year":"2006","unstructured":"Norman, J. T. & Fine, L. G. Intrarenal oxygenation in chronic renal failure. Clin. Exp. Pharmacol. Physiol. 33, 989\u2013996 (2006).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"1067_CR22","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1046\/j.1523-1755.2002.00631.x","volume":"62","author":"TA Sutton","year":"2002","unstructured":"Sutton, T. A., Fisher, C. J. & Molitoris, B. A. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int. 62, 1539\u20131549 (2002).","journal-title":"Kidney Int."},{"key":"1067_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167576","volume":"11","author":"KK McDonald","year":"2016","unstructured":"McDonald, K. K., Cooper, S., Danielzak, L. & Leask, R. L. Glycocalyx degradation induces a proinflammatory phenotype and increased leukocyte adhesion in cultured endothelial cells under flow. PLoS ONE 11, e0167576 (2016).","journal-title":"PLoS ONE"},{"key":"1067_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132047","volume":"10","author":"J Chen","year":"2015","unstructured":"Chen, J. et al. Interrelationship of multiple endothelial dysfunction biomarkers with chronic kidney disease. PLoS ONE 10, e0132047 (2015).","journal-title":"PLoS ONE"},{"key":"1067_CR25","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EA Hoste","year":"2015","unstructured":"Hoste, E. A. et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 41, 1411\u20131423 (2015).","journal-title":"Intensive Care Med."},{"key":"1067_CR26","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.4049\/jimmunol.168.3.1286","volume":"168","author":"TG Wolfs","year":"2002","unstructured":"Wolfs, T. G. et al. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-\u03b3 and TNF-\u03b1 mediated up-regulation during inflammation. J. Immunol. 168, 1286\u20131293 (2002).","journal-title":"J. Immunol."},{"key":"1067_CR27","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.mayocp.2025.06.005","volume":"100","author":"L Wei","year":"2025","unstructured":"Wei, L., Garces, J. P. D., Kashani, M., Dong, Y. & Kashani, K. B. Role of the complement system in acute kidney injury: a narrative review. Mayo Clin. Proc. 100, 1796\u20131809 (2025).","journal-title":"Mayo Clin. Proc."},{"key":"1067_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41581-021-00489-1","volume":"18","author":"G Molema","year":"2022","unstructured":"Molema, G., Zijlstra, J. G., van Meurs, M. & Kamps, J. Renal microvascular endothelial cell responses in sepsis-induced acute kidney injury. Nat. Rev. Nephrol. 18, 95\u2013112 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"1067_CR29","first-page":"725","volume":"143","author":"JW Fries","year":"1993","unstructured":"Fries, J. W. et al. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am. J. Pathol. 143, 725\u2013737 (1993).","journal-title":"Am. J. Pathol."},{"key":"1067_CR30","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1159\/000358238","volume":"6","author":"JM Herter","year":"2014","unstructured":"Herter, J. M., Rossaint, J., Spieker, T. & Zarbock, A. Adhesion molecules involved in neutrophil recruitment during sepsis-induced acute kidney injury. J. Innate Immun. 6, 597\u2013606 (2014).","journal-title":"J. Innate Immun."},{"key":"1067_CR31","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/apm.12585","volume":"124","author":"AG Kjaergaard","year":"2016","unstructured":"Kjaergaard, A. G., Dige, A., Nielsen, J. S., T\u00f8nnesen, E. & Krog, J. The use of the soluble adhesion molecules sE-selectin, sICAM-1, sVCAM-1, sPECAM-1 and their ligands CD11a and CD49d as diagnostic and prognostic biomarkers in septic and critically ill non-septic ICU patients. APMIS 124, 846\u2013855 (2016).","journal-title":"APMIS"},{"key":"1067_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2315-y","volume":"23","author":"WK Yu","year":"2019","unstructured":"Yu, W. K. et al. Vascular endothelial cadherin shedding is more severe in sepsis patients with severe acute kidney injury. Crit. Care 23, 18 (2019).","journal-title":"Crit. Care"},{"key":"1067_CR33","doi-asserted-by":"publisher","DOI":"10.1177\/10760296241238010","volume":"30","author":"Y Chi","year":"2024","unstructured":"Chi, Y. et al. Role of angiopoietin\/Tie2 system in sepsis: a potential therapeutic target. Clin. Appl. Thromb. Hemost. 30, 10760296241238010 (2024).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"1067_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1681\/ASN.2004060441","volume":"16","author":"JJ Boffa","year":"2005","unstructured":"Boffa, J. J. & Arendshorst, W. J. Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock. J. Am. Soc. Nephrol. 16, 117\u2013124 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1067_CR35","doi-asserted-by":"publisher","first-page":"F1044","DOI":"10.1152\/ajprenal.00136.2004","volume":"287","author":"W Wang","year":"2004","unstructured":"Wang, W. et al. Endothelial nitric oxide synthase-deficient mice exhibit increased susceptibility to endotoxin-induced acute renal failure. Am. J. Physiol. Ren. Physiol 287, F1044\u2013F1048 (2004).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1172\/JCI119551","volume":"100","author":"D Schwartz","year":"1997","unstructured":"Schwartz, D. et al. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J. Clin. Invest. 100, 439\u2013448 (1997).","journal-title":"J. Clin. Invest."},{"key":"1067_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1846-3","volume":"22","author":"A Margraf","year":"2018","unstructured":"Margraf, A. et al. 6% Hydroxyethyl starch (HES 130\/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice. Crit. Care 22, 111 (2018).","journal-title":"Crit. Care"},{"key":"1067_CR38","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202501-012OC","author":"K Oshima","year":"2025","unstructured":"Oshima, K. et al. Endothelial glycocalyx degradation in sepsis: analysis of the Crystalloid Liberal Or Vasopressors Early Resuscitation in Sepsis (CLOVERS) trial, a multicenter, phase 3, randomized trial. Ann. Am. Thorac. Soc. https:\/\/doi.org\/10.1513\/AnnalsATS.202501-012OC (2025).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"1067_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1535673","volume":"12","author":"Y Wang","year":"2025","unstructured":"Wang, Y., Zhang, Z., Qu, X. & Zhou, G. Role of the endothelial cell glycocalyx in sepsis-induced acute kidney injury. Front. Med. 12, 1535673 (2025).","journal-title":"Front. Med."},{"key":"1067_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbplus.2021.100094","volume":"12","author":"RC Sullivan","year":"2021","unstructured":"Sullivan, R. C., Rockstrom, M. D., Schmidt, E. P. & Hippensteel, J. A. Endothelial glycocalyx degradation during sepsis: causes and consequences. Matrix Biol. Plus 12, 100094 (2021).","journal-title":"Matrix Biol. Plus"},{"key":"1067_CR41","doi-asserted-by":"publisher","first-page":"F578","DOI":"10.1152\/ajprenal.00455.2005","volume":"291","author":"B Dursun","year":"2006","unstructured":"Dursun, B. et al. Caspases and calpain are independent mediators of cisplatin-induced endothelial cell necrosis. Am. J. Physiol. Ren. Physiol 291, F578\u2013F587 (2006).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR42","doi-asserted-by":"crossref","first-page":"F490","DOI":"10.1152\/ajpcell.1985.249.5.C490","volume":"249","author":"JA Winston","year":"1985","unstructured":"Winston, J. A. & Safirstein, R. Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. Am. J. Physiol. 249, F490\u2013F496 (1985).","journal-title":"Am. J. Physiol."},{"key":"1067_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0014-2999(02)01510-8","volume":"442","author":"SG Bhat","year":"2002","unstructured":"Bhat, S. G. et al. Cisplatin up-regulates the adenosine A1 receptor in the rat kidney. Eur. J. Pharmacol. 442, 251\u2013264 (2002).","journal-title":"Eur. J. Pharmacol."},{"key":"1067_CR44","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejphar.2007.04.063","volume":"569","author":"AH Khan","year":"2007","unstructured":"Khan, A. H., Sattar, M. A., Abdullah, N. A. & Johns, E. J. Influence of cisplatin-induced renal failure on the \u03b11-adrenoceptor subtype causing vasoconstriction in the kidney of the rat. Eur. J. Pharmacol. 569, 110\u2013118 (2007).","journal-title":"Eur. J. Pharmacol."},{"key":"1067_CR45","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00204-012-0821-7","volume":"86","author":"NA dos Santos","year":"2012","unstructured":"dos Santos, N. A., Carvalho Rodrigues, M. A., Martins, N. M. & dos Santos, A. C. Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update. Arch. Toxicol. 86, 1233\u20131250 (2012).","journal-title":"Arch. Toxicol."},{"key":"1067_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1097671","volume":"10","author":"HC Chen","year":"2023","unstructured":"Chen, H. C., Hou, H. Y., Sung, J. M. & Shieh, C. C. Deletion of NADPH oxidase 2 attenuates cisplatin-induced acute kidney injury through reducing ROS-induced proximal tubular cell injury and inflammation. Front. Med. 10, 1097671 (2023).","journal-title":"Front. Med."},{"key":"1067_CR47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/labinvest.2017.120","volume":"98","author":"XM Meng","year":"2018","unstructured":"Meng, X. M. et al. NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation. Lab. Invest. 98, 63\u201378 (2018).","journal-title":"Lab. Invest."},{"key":"1067_CR48","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1124\/jpet.107.119792","volume":"322","author":"S Faubel","year":"2007","unstructured":"Faubel, S. et al. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1\u03b2, IL-18, IL-6, and neutrophil infiltration in the kidney. J. Pharmacol. Exp. Ther. 322, 8\u201315 (2007).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1067_CR49","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1681\/ASN.2010091011","volume":"22","author":"A Akcay","year":"2011","unstructured":"Akcay, A. et al. IL-33 exacerbates acute kidney injury. J. Am. Soc. Nephrol. 22, 2057\u20132067 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1067_CR50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1124\/jpet.107.130161","volume":"324","author":"LH Lu","year":"2008","unstructured":"Lu, L. H. et al. Increased macrophage infiltration and fractalkine expression in cisplatin-induced acute renal failure in mice. J. Pharmacol. Exp. Ther. 324, 111\u2013117 (2008).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1067_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fneph.2024.1436896","volume":"4","author":"R Lyrio","year":"2024","unstructured":"Lyrio, R. et al. Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches. Front. Nephrol. 4, 1436896 (2024).","journal-title":"Front. Nephrol."},{"key":"1067_CR52","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1517\/14740330902942299","volume":"8","author":"MW Saif","year":"2009","unstructured":"Saif, M. W., Xyla, V., Makrilia, N., Bliziotis, I. & Syrigos, K. Thrombotic microangiopathy associated with gemcitabine: rare but real. Expert. Opin. Drug. Saf. 8, 257\u2013260 (2009).","journal-title":"Expert. Opin. Drug. Saf."},{"key":"1067_CR53","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/sj.ki.5002374","volume":"72","author":"JF Wetzels","year":"2007","unstructured":"Wetzels, J. F., Kiemeney, L. A., Swinkels, D. W., Willems, H. L. & den Heijer, M. Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int. 72, 632\u2013637 (2007).","journal-title":"Kidney Int."},{"key":"1067_CR54","doi-asserted-by":"publisher","first-page":"F542","DOI":"10.1152\/ajprenal.00287.2024","volume":"328","author":"M Borri","year":"2025","unstructured":"Borri, M., Jacobs, M. E., Carmeliet, P., Rabelink, T. J. & Dumas, S. J. Endothelial dysfunction in the aging kidney. Am. J. Physiol. Ren. Physiol 328, F542\u2013F562 (2025).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR55","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1523-1755.2004.00860.x","volume":"66","author":"G Rashid","year":"2004","unstructured":"Rashid, G., Benchetrit, S., Fishman, D. & Bernheim, J. Effect of advanced glycation end-products on gene expression and synthesis of TNF-\u03b1 and endothelial nitric oxide synthase by endothelial cells. Kidney Int. 66, 1099\u20131106 (2004).","journal-title":"Kidney Int."},{"key":"1067_CR56","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1160\/TH03-07-0491","volume":"92","author":"C Cerini","year":"2004","unstructured":"Cerini, C. et al. P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro. Thromb. Haemost. 92, 140\u2013150 (2004).","journal-title":"Thromb. Haemost."},{"key":"1067_CR57","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1159\/000452604","volume":"41","author":"CJ Lin","year":"2016","unstructured":"Lin, C. J. et al. Indoxyl sulfate impairs endothelial progenitor cells and might contribute to vascular dysfunction in patients with chronic kidney disease. Kidney Blood Press. Res. 41, 1025\u20131036 (2016).","journal-title":"Kidney Blood Press. Res."},{"key":"1067_CR58","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2011.10.023","volume":"220","author":"N Chitalia","year":"2012","unstructured":"Chitalia, N., Recio-Mayoral, A., Kaski, J. C. & Banerjee, D. Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients. Atherosclerosis 220, 265\u2013268 (2012).","journal-title":"Atherosclerosis"},{"key":"1067_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/625852","volume":"2010","author":"JR Wu-Wong","year":"2010","unstructured":"Wu-Wong, J. R. et al. Vitamin D receptor activation mitigates the impact of uremia on endothelial function in the 5\/6 nephrectomized rats. Int. J. Endocrinol. 2010, 625852 (2010).","journal-title":"Int. J. Endocrinol."},{"key":"1067_CR60","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1681\/ASN.2005101119","volume":"17","author":"SM Bode-B\u00f6ger","year":"2006","unstructured":"Bode-B\u00f6ger, S. M. et al. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J. Am. Soc. Nephrol. 17, 1128\u20131134 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1067_CR61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1476-5381.1994.tb13026.x","volume":"112","author":"RJ MacAllister","year":"1994","unstructured":"MacAllister, R. J., Fickling, S. A., Whitley, G. S. & Vallance, P. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. Br. J. Pharmacol. 112, 43\u201348 (1994).","journal-title":"Br. J. Pharmacol."},{"key":"1067_CR62","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/jth.12652","volume":"12","author":"CF Christiansen","year":"2014","unstructured":"Christiansen, C. F. et al. Kidney disease and risk of venous thromboembolism: a nationwide population-based case-control study. J. Thromb. Haemost. 12, 1449\u20131454 (2014).","journal-title":"J. Thromb. Haemost."},{"key":"1067_CR63","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/j.1538-7836.2010.03806.x","volume":"8","author":"O Dangel","year":"2010","unstructured":"Dangel, O. et al. Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition. J. Thromb. Haemost. 8, 1343\u20131352 (2010).","journal-title":"J. Thromb. Haemost."},{"key":"1067_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093423","volume":"9","author":"I Six","year":"2014","unstructured":"Six, I. et al. Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium. PLoS ONE 9, e93423 (2014).","journal-title":"PLoS ONE"},{"key":"1067_CR65","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12020-009-9181-3","volume":"35","author":"Y Maekawa","year":"2009","unstructured":"Maekawa, Y. et al. Klotho suppresses TNF-\u03b2-induced expression of adhesion molecules in the endothelium and attenuates NF-\u03baB activation. Endocrine 35, 341\u2013346 (2009).","journal-title":"Endocrine"},{"key":"1067_CR66","doi-asserted-by":"publisher","first-page":"E426","DOI":"10.1152\/ajpendo.00264.2014","volume":"307","author":"N Silswal","year":"2014","unstructured":"Silswal, N. et al. FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability. Am. J. Physiol. Endocrinol. Metab. 307, E426\u2013E436 (2014).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1067_CR67","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2215\/CJN.13121215","volume":"11","author":"RL Amdur","year":"2016","unstructured":"Amdur, R. L. et al. Inflammation and progression of CKD: the CRIC study. Clin. J. Am. Soc. Nephrol. 11, 1546\u20131556 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1067_CR68","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.atherosclerosis.2014.03.016","volume":"234","author":"JS Padberg","year":"2014","unstructured":"Padberg, J. S. et al. Damage of the endothelial glycocalyx in chronic kidney disease. Atherosclerosis 234, 335\u2013343 (2014).","journal-title":"Atherosclerosis"},{"key":"1067_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-02219-4","volume":"22","author":"H Liew","year":"2021","unstructured":"Liew, H., Roberts, M. A., Pope, A. & McMahon, L. P. Endothelial glycocalyx damage in kidney disease correlates with uraemic toxins and endothelial dysfunction. BMC Nephrol. 22, 21 (2021).","journal-title":"BMC Nephrol."},{"key":"1067_CR70","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/ndt\/gfad238","volume":"39","author":"ME Jacobs","year":"2024","unstructured":"Jacobs, M. E., de Vries, D. K., Engelse, M. A., Dumas, S. J. & Rabelink, T. J. Endothelial to mesenchymal transition in kidney fibrosis. Nephrol. Dial. Transpl. 39, 752\u2013760 (2024).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1067_CR71","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1681\/ASN.2013101137","volume":"26","author":"S Xavier","year":"2015","unstructured":"Xavier, S. et al. Curtailing endothelial TGF-\u03b2 signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD. J. Am. Soc. Nephrol. 26, 817\u2013829 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1067_CR72","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaz2597","volume":"13","author":"S Lovisa","year":"2020","unstructured":"Lovisa, S. et al. Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis. Sci. Signal. 13, eaaz2597 (2020).","journal-title":"Sci. Signal."},{"key":"1067_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810880","volume":"23","author":"Z Wang","year":"2022","unstructured":"Wang, Z. & Zhang, C. From AKI to CKD: maladaptive repair and the underlying mechanisms. Int. J. Mol. Sci. 23, 10880 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1067_CR74","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/SHK.0000000000001638","volume":"55","author":"GE Hatton","year":"2021","unstructured":"Hatton, G. E. et al. Endothelial dysfunction is associated with increased incidence, worsened severity, and prolonged duration of acute kidney injury after severe trauma. Shock 55, 311\u2013315 (2021).","journal-title":"Shock"},{"key":"1067_CR75","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2337\/dc20-1913","volume":"44","author":"HT Cheng","year":"2021","unstructured":"Cheng, H. T., Xu, X., Lim, P. S. & Hung, K. Y. Worldwide epidemiology of diabetes-related end-stage renal disease, 2000-2015. Diabetes Care 44, 89\u201397 (2021).","journal-title":"Diabetes Care"},{"key":"1067_CR76","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.cmet.2012.01.009","volume":"15","author":"W Wang","year":"2012","unstructured":"Wang, W. et al. Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab. 15, 186\u2013200 (2012).","journal-title":"Cell Metab."},{"key":"1067_CR77","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1084\/jem.20081188","volume":"205","author":"A El-Osta","year":"2008","unstructured":"El-Osta, A. et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 205, 2409\u20132417 (2008).","journal-title":"J. Exp. Med."},{"key":"1067_CR78","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1523-1755.2005.00067.x","volume":"67","author":"NH Kim","year":"2005","unstructured":"Kim, N. H. et al. Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy. Kidney Int. 67, 167\u2013177 (2005).","journal-title":"Kidney Int."},{"key":"1067_CR79","doi-asserted-by":"publisher","first-page":"F1665","DOI":"10.1152\/ajprenal.00495.2006","volume":"292","author":"T Nakagawa","year":"2007","unstructured":"Nakagawa, T. Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Am. J. Physiol. Ren. Physiol 292, F1665\u2013F1672 (2007).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR80","doi-asserted-by":"publisher","DOI":"10.1177\/1721727X231151526","author":"W Chu","year":"2023","unstructured":"Chu, W., Ma, L.-L., Li, B.-X. & Li, M.-C. Clinical significance of vascular endothelial growth factor and endothelin-1 in serum levels as novel indicators for predicting the progression of diabetic nephropathy. Eur. J. Inflamm. https:\/\/doi.org\/10.1177\/1721727X231151526 (2023).","journal-title":"Eur. J. Inflamm."},{"key":"1067_CR81","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/sj.ki.5002567","volume":"73","author":"C Rosenberger","year":"2008","unstructured":"Rosenberger, C. et al. Adaptation to hypoxia in the diabetic rat kidney. Kidney Int. 73, 34\u201342 (2008).","journal-title":"Kidney Int."},{"key":"1067_CR82","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.2337\/diabetes.48.6.1300","volume":"48","author":"FC Huvers","year":"1999","unstructured":"Huvers, F. C. et al. Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes 48, 1300\u20131307 (1999).","journal-title":"Diabetes"},{"key":"1067_CR83","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/837421","volume":"2014","author":"Y Takiyama","year":"2014","unstructured":"Takiyama, Y. & Haneda, M. Hypoxia in diabetic kidneys. Biomed. Res. Int. 2014, 837421 (2014).","journal-title":"Biomed. Res. Int."},{"key":"1067_CR84","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","volume":"16","author":"JA Forsythe","year":"1996","unstructured":"Forsythe, J. A. et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16, 4604\u20134613 (1996).","journal-title":"Mol. Cell Biol."},{"key":"1067_CR85","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.molcel.2018.01.010","volume":"69","author":"J Xiong","year":"2018","unstructured":"Xiong, J. et al. A metabolic basis for endothelial-to-mesenchymal transition. Mol. Cell 69, 689\u2013698.e7 (2018).","journal-title":"Mol. Cell"},{"key":"1067_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102390","volume":"24","author":"SP Srivastava","year":"2021","unstructured":"Srivastava, S. P. et al. Endothelial SIRT3 regulates myofibroblast metabolic shifts in diabetic kidneys. iScience 24, 102390 (2021).","journal-title":"iScience"},{"key":"1067_CR87","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1172\/JCI125116","volume":"129","author":"J Kuriakose","year":"2019","unstructured":"Kuriakose, J. et al. Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis. J. Clin. Invest. 129, 2251\u20132265 (2019).","journal-title":"J. Clin. Invest."},{"key":"1067_CR88","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1365-2249.1991.tb05714.x","volume":"85","author":"DP D\u2019Cruz","year":"1991","unstructured":"D\u2019Cruz, D. P. et al. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin. Exp. Immunol. 85, 254\u2013261 (1991).","journal-title":"Clin. Exp. Immunol."},{"key":"1067_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163085","volume":"11","author":"A Kondo","year":"2016","unstructured":"Kondo, A. et al. The level of IgA antibodies to endothelial cells correlates with histological evidence of disease activity in patients with lupus nephritis. PLoS ONE 11, e0163085 (2016).","journal-title":"PLoS ONE"},{"key":"1067_CR90","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.semnephrol.2015.08.006","volume":"35","author":"DJ Birmingham","year":"2015","unstructured":"Birmingham, D. J. & Hebert, L. A. The complement system in lupus nephritis. Semin. Nephrol. 35, 444\u2013454 (2015).","journal-title":"Semin. Nephrol."},{"key":"1067_CR91","doi-asserted-by":"publisher","first-page":"786","DOI":"10.4049\/jimmunol.164.2.786","volume":"164","author":"H Watanabe","year":"2000","unstructured":"Watanabe, H. et al. Modulation of renal disease in MRL\/lpr mice genetically deficient in the alternative complement pathway factor B. J. Immunol. 164, 786\u2013794 (2000).","journal-title":"J. Immunol."},{"key":"1067_CR92","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1681\/ASN.2014101000","volume":"26","author":"N Maillard","year":"2015","unstructured":"Maillard, N. et al. Current understanding of the role of complement in IgA nephropathy. J. Am. Soc. Nephrol. 26, 1503\u20131512 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1067_CR93","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrneph.2017.37","volume":"13","author":"M Chen","year":"2017","unstructured":"Chen, M., Jayne, D. R. W. & Zhao, M. H. Complement in ANCA-associated vasculitis: mechanisms and implications for management. Nat. Rev. Nephrol. 13, 359\u2013367 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"1067_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.599974","volume":"11","author":"JJE Koopman","year":"2020","unstructured":"Koopman, J. J. E., van Essen, M. F., Rennke, H. G., de Vries, A. P. J. & van Kooten, C. Deposition of the membrane attack complex in healthy and diseased human kidneys. Front. Immunol. 11, 599974 (2020).","journal-title":"Front. Immunol."},{"key":"1067_CR95","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s10067-007-0580-7","volume":"26","author":"A Sabry","year":"2007","unstructured":"Sabry, A. et al. Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis. Clin. Rheumatol. 26, 1819\u20131823 (2007).","journal-title":"Clin. Rheumatol."},{"key":"1067_CR96","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/ki.1992.367","volume":"42","author":"RP Wuthrich","year":"1992","unstructured":"Wuthrich, R. P. Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int. 42, 903\u2013914 (1992).","journal-title":"Kidney Int."},{"key":"1067_CR97","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1399-0039.1981.tb01382.x","volume":"18","author":"H Scott","year":"1981","unstructured":"Scott, H., Brandtzaeg, P., Hirschberg, H., Solheim, B. G. & Thorsby, E. Vascular and renal distribution of HLA-DR-like antigens. Tissue Antigens 18, 195\u2013202 (1981).","journal-title":"Tissue Antigens"},{"key":"1067_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0008-8749(88)90046-9","volume":"111","author":"JF Wedgwood","year":"1988","unstructured":"Wedgwood, J. F., Hatam, L. & Bonagura, V. R. Effect of interferon-\u03b3 and tumor necrosis factor on the expression of class I and class II major histocompatibility molecules by cultured human umbilical vein endothelial cells. Cell Immunol. 111, 1\u20139 (1988).","journal-title":"Cell Immunol."},{"key":"1067_CR99","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.4049\/jimmunol.1600108","volume":"199","author":"JJ Buie","year":"2017","unstructured":"Buie, J. J., Renaud, L. L., Muise-Helmericks, R. & Oates, J. C. IFN-\u03b1 negatively regulates the expression of endothelial nitric oxide synthase and nitric oxide production: implications for systemic lupus erythematosus. J. Immunol. 199, 1979\u20131988 (2017).","journal-title":"J. Immunol."},{"key":"1067_CR100","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2018-000294","volume":"6","author":"JN Jones Buie","year":"2019","unstructured":"Jones Buie, J. N., Pleasant Jenkins, D., Muise-Helmericks, R. & Oates, J. C. L-sepiapterin restores SLE serum-induced markers of endothelial function in endothelial cells. Lupus Sci. Med. 6, e000294 (2019).","journal-title":"Lupus Sci. Med."},{"key":"1067_CR101","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1002\/art.23035","volume":"56","author":"PY Lee","year":"2007","unstructured":"Lee, P. Y. et al. Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum. 56, 3759\u20133769 (2007).","journal-title":"Arthritis Rheum."},{"key":"1067_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064650","volume":"8","author":"GS Gilkeson","year":"2013","unstructured":"Gilkeson, G. S. et al. Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis. PLoS ONE 8, e64650 (2013).","journal-title":"PLoS ONE"},{"key":"1067_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01130","volume":"9","author":"H Cardinal","year":"2018","unstructured":"Cardinal, H., Dieud\u00e9, M. & H\u00e9bert, M. J. Endothelial dysfunction in kidney transplantation. Front. Immunol. 9, 1130 (2018).","journal-title":"Front. Immunol."},{"key":"1067_CR104","doi-asserted-by":"publisher","first-page":"F338","DOI":"10.1152\/ajprenal.00169.2002","volume":"284","author":"DP Basile","year":"2003","unstructured":"Basile, D. P., Donohoe, D. L., Roethe, K. & Mattson, D. L. Chronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage. Am. J. Physiol. Ren. Physiol 284, F338\u2013F348 (2003).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR105","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1034\/j.1399-0012.16.s8.10.x","volume":"16","author":"Y Nakagawa","year":"2002","unstructured":"Nakagawa, Y. et al. The clinical significance of antibody to vascular endothelial cells after renal transplantation. Clin. Transpl. 16, 51\u201357 (2002).","journal-title":"Clin. Transpl."},{"key":"1067_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88411-4","volume":"11","author":"H Tejeda-Mora","year":"2021","unstructured":"Tejeda-Mora, H. et al. Circulating endothelial cells transiently increase in peripheral blood after kidney transplantation. Sci. Rep. 11, 8915 (2021).","journal-title":"Sci. Rep."},{"key":"1067_CR107","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41577-022-00694-4","volume":"22","author":"J Amersfoort","year":"2022","unstructured":"Amersfoort, J., Eelen, G. & Carmeliet, P. Immunomodulation by endothelial cells \u2014 partnering up with the immune system? Nat. Rev. Immunol. 22, 576\u2013588 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1067_CR108","doi-asserted-by":"publisher","first-page":"F947","DOI":"10.1152\/ajprenal.90601.2008","volume":"296","author":"SC Satchell","year":"2009","unstructured":"Satchell, S. C. & Braet, F. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am. J. Physiol. Ren. Physiol 296, F947\u2013F956 (2009).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR109","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/08860229709026259","volume":"19","author":"MA Turman","year":"1997","unstructured":"Turman, M. A. & Bates, C. M. Susceptibility of human proximal tubular cells to hypoxia: effect of hypoxic preconditioning and comparison to glomerular cells. Ren. Fail. 19, 47\u201360 (1997).","journal-title":"Ren. Fail."},{"key":"1067_CR110","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1097\/01.LAB.0000029620.13097.19","volume":"82","author":"S Satoh","year":"2002","unstructured":"Satoh, S. et al. Glomerular endothelium exhibits enhanced expression of costimulatory adhesion molecules, CD80 and CD86, by warm ischemia\/reperfusion injury in rats. Lab. Invest. 82, 1209\u20131217 (2002).","journal-title":"Lab. Invest."},{"key":"1067_CR111","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1006\/jsre.2001.6275","volume":"102","author":"H Ushigome","year":"2002","unstructured":"Ushigome, H. et al. The role of tissue factor in renal ischemic reperfusion injury of the rat. J. Surg. Res. 102, 102\u2013109 (2002).","journal-title":"J. Surg. Res."},{"key":"1067_CR112","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.cellsig.2016.04.001","volume":"28","author":"Z Jing","year":"2016","unstructured":"Jing, Z., Wei-Jie, Y., Yi-Feng, Z. G. & Jing, H. Downregulation of syndecan-1 induce glomerular endothelial cell dysfunction through modulating internalization of VEGFR-2. Cell Signal. 28, 826\u2013837 (2016).","journal-title":"Cell Signal."},{"key":"1067_CR113","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1172\/JCI17423","volume":"111","author":"V Eremina","year":"2003","unstructured":"Eremina, V. et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111, 707\u2013716 (2003).","journal-title":"J. Clin. Invest."},{"key":"1067_CR114","doi-asserted-by":"publisher","first-page":"F928","DOI":"10.1152\/ajprenal.00596.2007","volume":"294","author":"DP Basile","year":"2008","unstructured":"Basile, D. P., Fredrich, K., Chelladurai, B., Leonard, E. C. & Parrish, A. R. Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor. Am. J. Physiol. Ren. Physiol 294, F928\u2013F936 (2008).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR115","doi-asserted-by":"publisher","first-page":"F377","DOI":"10.1152\/ajprenal.00354.2011","volume":"303","author":"MP Hutchens","year":"2012","unstructured":"Hutchens, M. P., Fujiyoshi, T., Komers, R., Herson, P. S. & Anderson, S. Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo. Am. J. Physiol. Ren. Physiol 303, F377\u2013F385 (2012).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR116","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.kint.2022.03.025","volume":"102","author":"CC Estrada","year":"2022","unstructured":"Estrada, C. C. et al. Endothelial-specific loss of Kr\u00fcppel-like factor 4 triggers complement-mediated endothelial injury. Kidney Int. 102, 58\u201377 (2022).","journal-title":"Kidney Int."},{"key":"1067_CR117","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1681\/ASN.2015040460","volume":"27","author":"T Yoshida","year":"2016","unstructured":"Yoshida, T., Yamashita, M., Iwai, M. & Hayashi, M. Endothelial Kr\u00fcppel-like factor 4 mediates the protective effect of statins against ischemic AKI. J. Am. Soc. Nephrol. 27, 1379\u20131388 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1067_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021415","volume":"24","author":"PG Vall\u00e9s","year":"2023","unstructured":"Vall\u00e9s, P. G. et al. Toll-like receptor 4 in acute kidney injury. Int. J. Mol. Sci. 24, 1415 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1067_CR119","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1046\/j.1523-1755.1999.00473.x","volume":"55","author":"UK Messmer","year":"1999","unstructured":"Messmer, U. K., Briner, V. A. & Pfeilschifter, J. Tumor necrosis factor-\u03b1 and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int. 55, 2322\u20132337 (1999).","journal-title":"Kidney Int."},{"key":"1067_CR120","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/ki.2013.286","volume":"85","author":"C Xu","year":"2014","unstructured":"Xu, C. et al. TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis. Kidney Int. 85, 72\u201381 (2014).","journal-title":"Kidney Int."},{"key":"1067_CR121","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.lfs.2014.03.013","volume":"102","author":"S Jesmin","year":"2014","unstructured":"Jesmin, S. et al. Effects of protease activated receptor (PAR)2 blocking peptide on endothelin-1 levels in kidney tissues in endotoxemic rat mode. Life Sci. 102, 127\u2013133 (2014).","journal-title":"Life Sci."},{"key":"1067_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1841-8","volume":"21","author":"H Okada","year":"2017","unstructured":"Okada, H. et al. Three-dimensional ultrastructure of capillary endothelial glycocalyx under normal and experimental endotoxemic conditions. Crit. Care 21, 261 (2017).","journal-title":"Crit. Care"},{"key":"1067_CR123","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.ajpath.2015.12.008","volume":"186","author":"M Garsen","year":"2016","unstructured":"Garsen, M. et al. Heparanase is essential for the development of acute experimental glomerulonephritis. Am. J. Pathol. 186, 805\u2013815 (2016).","journal-title":"Am. J. Pathol."},{"key":"1067_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/phy2.153","volume":"1","author":"MI Lygizos","year":"2013","unstructured":"Lygizos, M. I. et al. Heparanase mediates renal dysfunction during early sepsis in mice. Physiol. Rep. 1, e00153 (2013).","journal-title":"Physiol. Rep."},{"key":"1067_CR125","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/SHK.0000000000000841","volume":"48","author":"A Aslan","year":"2017","unstructured":"Aslan, A. et al. Organ-specific differences in endothelial permeability-regulating molecular responses in mouse and human sepsis. Shock 48, 69\u201377 (2017).","journal-title":"Shock"},{"key":"1067_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.981578","volume":"13","author":"FF He","year":"2022","unstructured":"He, F. F. et al. Sepsis-induced AKI: from pathogenesis to therapeutic approaches. Front. Pharmacol. 13, 981578 (2022).","journal-title":"Front. Pharmacol."},{"key":"1067_CR127","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2353\/ajpath.2006.050834","volume":"168","author":"AS Maharaj","year":"2006","unstructured":"Maharaj, A. S., Saint-Geniez, M., Maldonado, A. E. & D\u2019Amore, P. A. Vascular endothelial growth factor localization in the adult. Am. J. Pathol. 168, 639\u2013648 (2006).","journal-title":"Am. J. Pathol."},{"key":"1067_CR128","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1161\/ATVBAHA.107.150482","volume":"27","author":"CM Findley","year":"2007","unstructured":"Findley, C. M., Cudmore, M. J., Ahmed, A. & Kontos, C. D. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase\/Akt dependent pathway to modulate Tie2 signaling. Arterioscler. Thromb. Vasc. Biol. 27, 2619\u20132626 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1067_CR129","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00441-014-1812-1","volume":"355","author":"V K\u00fcppers","year":"2014","unstructured":"K\u00fcppers, V., Vockel, M., Nottebaum, A. F. & Vestweber, D. Phosphatases and kinases as regulators of the endothelial barrier function. Cell Tissue Res. 355, 577\u2013586 (2014).","journal-title":"Cell Tissue Res."},{"key":"1067_CR130","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1167\/iovs.10-6386","volume":"52","author":"S Rangasamy","year":"2011","unstructured":"Rangasamy, S., Srinivasan, R., Maestas, J., McGuire, P. G. & Das, A. A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 52, 3784\u20133791 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1067_CR131","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000045565","volume":"84","author":"D Baran","year":"2000","unstructured":"Baran, D., Vendeville, B., Ogborn, M. & Katz, N. Cell adhesion molecule expression in murine lupus-like nephritis induced by lipopolysaccharide. Nephron 84, 167\u2013176 (2000).","journal-title":"Nephron"},{"key":"1067_CR132","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00134-009-1723-x","volume":"36","author":"N Lerolle","year":"2010","unstructured":"Lerolle, N. et al. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med. 36, 471\u2013478 (2010).","journal-title":"Intensive Care Med."},{"key":"1067_CR133","doi-asserted-by":"publisher","first-page":"F505","DOI":"10.1152\/ajprenal.00041.2021","volume":"321","author":"H Trachtman","year":"2021","unstructured":"Trachtman, H. et al. Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome. Am. J. Physiol. Ren. Physiol 321, F505\u2013F516 (2021).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR134","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.ekir.2022.03.007","volume":"7","author":"M Morita","year":"2022","unstructured":"Morita, M. et al. Diverse alterations of glomerular capillary networks in focal segmental glomerular sclerosis. Kidney Int. Rep. 7, 1229\u20131240 (2022).","journal-title":"Kidney Int. Rep."},{"key":"1067_CR135","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1172\/JCI71195","volume":"124","author":"I Daehn","year":"2014","unstructured":"Daehn, I. et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J. Clin. Invest. 124, 1608\u20131621 (2014).","journal-title":"J. Clin. Invest."},{"key":"1067_CR136","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ekir.2021.11.037","volume":"7","author":"C Bauer","year":"2022","unstructured":"Bauer, C. et al. Minimal change disease is associated with endothelial glycocalyx degradation and endothelial activation. Kidney Int. Rep. 7, 797\u2013809 (2022).","journal-title":"Kidney Int. Rep."},{"key":"1067_CR137","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1681\/ASN.2019080825","volume":"31","author":"V Royal","year":"2020","unstructured":"Royal, V. et al. Ultrastructural characterization of proteinuric patients predicts clinical outcomes. J. Am. Soc. Nephrol. 31, 841\u2013854 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1067_CR138","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1016\/j.ekir.2025.04.055","volume":"10","author":"C Bauer","year":"2025","unstructured":"Bauer, C. et al. Serum syndecan-1 is associated with kidney and cardiovascular outcomes in idiopathic nephrotic syndrome. Kidney Int. Rep. 10, 2732\u20132740 (2025).","journal-title":"Kidney Int. Rep."},{"key":"1067_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055027","volume":"8","author":"YB Sun","year":"2013","unstructured":"Sun, Y. B. et al. Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy. PLoS ONE 8, e55027 (2013).","journal-title":"PLoS ONE"},{"key":"1067_CR140","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.816400","volume":"13","author":"J Yang","year":"2022","unstructured":"Yang, J. & Liu, Z. Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy. Front. Endocrinol. 13, 816400 (2022).","journal-title":"Front. Endocrinol."},{"key":"1067_CR141","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2337\/diabetes.55.04.06.db05-1619","volume":"55","author":"M Nieuwdorp","year":"2006","unstructured":"Nieuwdorp, M. et al. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 55, 1127\u20131132 (2006).","journal-title":"Diabetes"},{"key":"1067_CR142","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2337\/diab.44.5.561","volume":"44","author":"CD Stehouwer","year":"1995","unstructured":"Stehouwer, C. D., Fischer, H. R., van Kuijk, A. W., Polak, B. C. & Donker, A. J. Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 44, 561\u2013564 (1995).","journal-title":"Diabetes"},{"key":"1067_CR143","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1042\/cs0970037","volume":"97","author":"P Clausen","year":"1999","unstructured":"Clausen, P., Feldt-Rasmussen, B., Jensen, G. & Jensen, J. S. Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study. Clin. Sci. 97, 37\u201343 (1999).","journal-title":"Clin. Sci."},{"key":"1067_CR144","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2337\/db16-0695","volume":"66","author":"H Qi","year":"2017","unstructured":"Qi, H. et al. Glomerular endothelial mitochondrial dysfunction is essential and characteristic of diabetic kidney disease susceptibility. Diabetes 66, 763\u2013778 (2017).","journal-title":"Diabetes"},{"key":"1067_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00605-x","volume":"18","author":"GA Casalena","year":"2020","unstructured":"Casalena, G. A. et al. The diabetic microenvironment causes mitochondrial oxidative stress in glomerular endothelial cells and pathological crosstalk with podocytes. Cell Commun. Signal. 18, 105 (2020).","journal-title":"Cell Commun. Signal."},{"key":"1067_CR146","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s00125-007-0666-4","volume":"50","author":"M Nieuwdorp","year":"2007","unstructured":"Nieuwdorp, M. et al. Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis. Diabetologia 50, 1288\u20131293 (2007).","journal-title":"Diabetologia"},{"key":"1067_CR147","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1159\/000077594","volume":"97","author":"Y Kikuchi","year":"2004","unstructured":"Kikuchi, Y. et al. Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin-induced diabetic kidneys. Nephron Exp. Nephrol. 97, e17\u2013e25 (2004).","journal-title":"Nephron Exp. Nephrol."},{"key":"1067_CR148","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2337\/diab.46.12.2075","volume":"46","author":"H Sugimoto","year":"1997","unstructured":"Sugimoto, H. et al. Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes 46, 2075\u20132081 (1997).","journal-title":"Diabetes"},{"key":"1067_CR149","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbrc.2017.01.068","volume":"484","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Qu, Y., Niu, T., Wang, H. & Liu, K. O-GlcNAc modification of Sp1 mediates hyperglycaemia-induced ICAM-1 up-regulation in endothelial cells. Biochem. Biophys. Res. Commun. 484, 79\u201384 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1067_CR150","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.dsx.2017.12.028","volume":"12","author":"Z Karimi","year":"2018","unstructured":"Karimi, Z. et al. Intercellular adhesion molecule-1 in diabetic patients with and without microalbuminuria. Diabetes Metab. Syndr. 12, 365\u2013368 (2018).","journal-title":"Diabetes Metab. Syndr."},{"key":"1067_CR151","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1161\/CIRCRESAHA.124.325218","volume":"136","author":"Z Hu","year":"2025","unstructured":"Hu, Z. et al. Loss of the endothelial glycocalyx component EMCN lLeads to glomerular impairment. Circ. Res. 136, 59\u201374 (2025).","journal-title":"Circ. Res."},{"key":"1067_CR152","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00125-010-2034-z","volume":"54","author":"D Veron","year":"2011","unstructured":"Veron, D. et al. Podocyte vascular endothelial growth factor (Vegf164) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes. Diabetologia 54, 1227\u20131241 (2011).","journal-title":"Diabetologia"},{"key":"1067_CR153","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02552-5","volume":"23","author":"YC Hu","year":"2021","unstructured":"Hu, Y. C., Tsai, I. J., Hsu, H. Y., Chiang, B. L. & Yang, Y. H. Identification of monoclonal antibodies against human renal glomerular endothelial cells in lupus nephritis that induce endothelial interferon-\u03b1 production. Arthritis Res. Ther. 23, 171 (2021).","journal-title":"Arthritis Res. Ther."},{"key":"1067_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-44868-y","volume":"9","author":"P Dimou","year":"2019","unstructured":"Dimou, P. et al. The human glomerular endothelial cells are potent pro-inflammatory contributors in an in vitro model of lupus nephritis. Sci. Rep. 9, 8348 (2019).","journal-title":"Sci. Rep."},{"key":"1067_CR155","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1272\/jnms.82.27","volume":"82","author":"E Fujita","year":"2015","unstructured":"Fujita, E. et al. Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis. J. Nippon. Med. Sch. 82, 27\u201335 (2015).","journal-title":"J. Nippon. Med. Sch."},{"key":"1067_CR156","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96492","volume":"3","author":"F Olaru","year":"2018","unstructured":"Olaru, F. et al. Intracapillary immune complexes recruit and activate slan-expressing CD16+ monocytes in human lupus nephritis. JCI Insight 3, e96492 (2018).","journal-title":"JCI Insight"},{"key":"1067_CR157","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/ped.14579","volume":"63","author":"S Hashimoto","year":"2021","unstructured":"Hashimoto, S. et al. Expression of IFN-induced transmembrane protein 1 in glomerular endothelial cells. Pediatr. Int. 63, 1075\u20131081 (2021).","journal-title":"Pediatr. Int."},{"key":"1067_CR158","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2224890","volume":"45","author":"T Karasawa","year":"2023","unstructured":"Karasawa, T. et al. Expression of interferon-stimulated gene 20 (ISG20), an antiviral effector protein, in glomerular endothelial cells: possible involvement of ISG20 in lupus nephritis. Ren. Fail. 45, 2224890 (2023).","journal-title":"Ren. Fail."},{"key":"1067_CR159","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3109\/01913123.2013.814738","volume":"37","author":"CJ Lee","year":"2013","unstructured":"Lee, C. J. et al. The clinicopathologic significance of endothelial tubuloreticular inclusions in glomerular diseases. Ultrastruct. Pathol. 37, 386\u2013394 (2013).","journal-title":"Ultrastruct. Pathol."},{"key":"1067_CR160","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-022-00305-9","volume":"19","author":"T Zhang","year":"2022","unstructured":"Zhang, T. et al. Excessive IL-15 promotes cytotoxic CD4+CD28\u2212 T cell-mediated renal injury in lupus nephritis. Immun. Ageing 19, 50 (2022).","journal-title":"Immun. Ageing"},{"key":"1067_CR161","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131252","volume":"5","author":"H Kadoya","year":"2020","unstructured":"Kadoya, H. et al. Essential role and therapeutic targeting of the glomerular endothelial glycocalyx in lupus nephritis. JCI Insight 5, e131252 (2020).","journal-title":"JCI Insight"},{"key":"1067_CR162","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9993971","volume":"2021","author":"T Yu","year":"2021","unstructured":"Yu, T. et al. Extracellular HMGB1 induced glomerular endothelial cell injury via TLR4\/MyD88 signaling pathway in lupus nephritis. Mediators Inflamm. 2021, 9993971 (2021).","journal-title":"Mediators Inflamm."},{"key":"1067_CR163","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052853","volume":"25","author":"E Stasi","year":"2024","unstructured":"Stasi, E., Sciascia, S., Naretto, C., Baldovino, S. & Roccatello, D. Lymphatic system and the kidney: from lymphangiogenesis to renal inflammation and fibrosis development. Int. J. Mol. Sci. 25, 2853 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1067_CR164","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00251","volume":"10","author":"PS Russell","year":"2019","unstructured":"Russell, P. S., Hong, J., Windsor, J. A., Itkin, M. & Phillips, A. R. J. Renal lymphatics: anatomy, physiology, and clinical implications. Front. Physiol. 10, 251 (2019).","journal-title":"Front. Physiol."},{"key":"1067_CR165","doi-asserted-by":"publisher","DOI":"10.1148\/rg.230065","volume":"44","author":"H Takahashi","year":"2024","unstructured":"Takahashi, H. et al. Imaging of perirenal and intrarenal lymphatic vessels: anatomy-based approach. Radiographics 44, e230065 (2024).","journal-title":"Radiographics"},{"key":"1067_CR166","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.577584","volume":"11","author":"L Gutierrez-Miranda","year":"2020","unstructured":"Gutierrez-Miranda, L. & Yaniv, K. Cellular origins of the lymphatic endothelium: implications for cancer lymphangiogenesis. Front. Physiol. 11, 577584 (2020).","journal-title":"Front. Physiol."},{"key":"1067_CR167","doi-asserted-by":"publisher","unstructured":"Melkonian, A. L. et al. Single-cell RNA sequencing and spatial transcriptomics reveal unique subpopulations of infiltrating macrophages and dendritic dells following AKI. Am. J. Physiol. Renal Physiol. https:\/\/doi.org\/10.1152\/ajprenal.00059.2025 (2025).","DOI":"10.1152\/ajprenal.00059.2025"},{"key":"1067_CR168","doi-asserted-by":"crossref","unstructured":"Erman, E. N., Nath, M. C., Cheung, M. D., Agarwal, A. & George, J. F. in Regenerative Nephrology 2nd edn (ed Goligorsky, M. S.) 93\u2013102 (Academic Press, 2022).","DOI":"10.1016\/B978-0-12-823318-4.00017-2"},{"key":"1067_CR169","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1535-6108(02)00051-X","volume":"1","author":"K Alitalo","year":"2002","unstructured":"Alitalo, K. & Carmeliet, P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1, 219\u2013227 (2002).","journal-title":"Cancer Cell"},{"key":"1067_CR170","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1527971","volume":"13","author":"KG Kuonqui","year":"2025","unstructured":"Kuonqui, K. G. et al. Regulation of VEGFR3 signaling in lymphatic endothelial cells. Front. Cell Dev. Biol. 13, 1527971 (2025).","journal-title":"Front. Cell Dev. Biol."},{"key":"1067_CR171","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41374-019-0259-0","volume":"99","author":"A Zarjou","year":"2019","unstructured":"Zarjou, A. et al. Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease. Lab. Invest. 99, 1376\u20131388 (2019).","journal-title":"Lab. Invest."},{"key":"1067_CR172","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176577","volume":"134","author":"J Du","year":"2024","unstructured":"Du, J. et al. The mechanosensory channel PIEZO1 functions upstream of angiopoietin\/TIE\/FOXO1 signaling in lymphatic development. J. Clin. Invest. 134, e176577 (2024).","journal-title":"J. Clin. Invest."},{"key":"1067_CR173","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1177\/1535370220983235","volume":"246","author":"HA Creed","year":"2021","unstructured":"Creed, H. A. & Rutkowski, J. M. Emerging roles for lymphatics in acute kidney injury: beneficial or maleficent. Exp. Biol. Med. 246, 845\u2013850 (2021).","journal-title":"Exp. Biol. Med."},{"key":"1067_CR174","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1681\/ASN.0000000000000325","volume":"35","author":"HA Creed","year":"2024","unstructured":"Creed, H. A. et al. Single-cell RNA sequencing identifies response of renal lymphatic endothelial cells to acute kidney injury. J. Am. Soc. Nephrol. 35, 549\u2013565 (2024).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1067_CR175","doi-asserted-by":"publisher","first-page":"F675","DOI":"10.1152\/ajprenal.00186.2021","volume":"321","author":"LM Black","year":"2021","unstructured":"Black, L. M. et al. VEGFR3 tyrosine kinase inhibition aggravates cisplatin nephrotoxicity. Am. J. Physiol. Ren. Physiol 321, F675\u2013f688 (2021).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR176","doi-asserted-by":"publisher","first-page":"F869","DOI":"10.1152\/ajprenal.00120.2024","volume":"327","author":"G Ghajar-Rahimi","year":"2024","unstructured":"Ghajar-Rahimi, G. et al. Acute kidney injury results in long-term alterations of kidney lymphatics in mice. Am. J. Physiol. Ren. Physiol 327, F869\u2013F884 (2024).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR177","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.198992","author":"AL Melkonian","year":"2026","unstructured":"Melkonian, A. L. et al. NF-\u03baB driven lymphangiogenesis impacts kidney function via a VEGFR-3 mediated pathway. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.198992 (2026).","journal-title":"JCI Insight"},{"key":"1067_CR178","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15094","volume":"9","author":"G Baranwal","year":"2021","unstructured":"Baranwal, G. et al. Expanded renal lymphatics improve recovery following kidney injury. Physiol. Rep. 9, e15094 (2021).","journal-title":"Physiol. Rep."},{"key":"1067_CR179","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1002\/j.2040-4603.2023.tb00276.x","volume":"13","author":"PS Russell","year":"2023","unstructured":"Russell, P. S., Itkin, M., Windsor, J. A. & Phillips, A. R. J. Kidney Lymphatics. Compr. Physiol. 13, 4945\u20134984 (2023).","journal-title":"Compr. Physiol."},{"key":"1067_CR180","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/labinvest.2017.77","volume":"97","author":"S Hasegawa","year":"2017","unstructured":"Hasegawa, S. et al. Vascular endothelial growth factor-C ameliorates renal interstitial fibrosis through lymphangiogenesis in mouse unilateral ureteral obstruction. Lab. Invest. 97, 1439\u20131452 (2017).","journal-title":"Lab. Invest."},{"key":"1067_CR181","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/ki.2012.312","volume":"83","author":"AS Lee","year":"2013","unstructured":"Lee, A. S. et al. Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. Kidney Int. 83, 50\u201362 (2013).","journal-title":"Kidney Int."},{"key":"1067_CR182","doi-asserted-by":"publisher","DOI":"10.34067\/kid.0000000671","author":"S Kannan","year":"2024","unstructured":"Kannan, S. et al. Therapeutically-induced lymphangiogenesis is ineffective in resolving established kidney disease in mice. Kidney360 https:\/\/doi.org\/10.34067\/kid.0000000671 (2024).","journal-title":"Kidney360"},{"key":"1067_CR183","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw5075","volume":"5","author":"G Pei","year":"2019","unstructured":"Pei, G. et al. Lymphangiogenesis in kidney and lymph node mediates renal inflammation and fibrosis. Sci. Adv. 5, eaaw5075 (2019).","journal-title":"Sci. Adv."},{"key":"1067_CR184","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.195176","author":"J Liu","year":"2026","unstructured":"Liu, J. et al. LYVE1 ectodomain shedding blunts lymphatic transmigration and clearance of macrophages during kidney injury. J. Clin. Invest. https:\/\/doi.org\/10.1172\/jci.insight.195176 (2026).","journal-title":"J. Clin. Invest."},{"key":"1067_CR185","first-page":"588","volume":"49","author":"JG McDermott","year":"2024","unstructured":"McDermott, J. G. et al. Inflammatory alterations to renal lymphatic endothelial cell gene expression in mouse models of hypertension. Kidney Blood Press. Res. 49, 588\u2013604 (2024).","journal-title":"Kidney Blood Press. Res."},{"key":"1067_CR186","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.312765","volume":"122","author":"CA Lopez Gelston","year":"2018","unstructured":"Lopez Gelston, C. A. et al. Enhancing renal lymphatic expansion prevents hypertension in mice. Circ. Res. 122, 1094\u20131101 (2018).","journal-title":"Circ. Res."},{"key":"1067_CR187","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1042\/CS20220547","volume":"136","author":"BL Goodlett","year":"2022","unstructured":"Goodlett, B. L. et al. Genetically inducing renal lymphangiogenesis attenuates hypertension in mice. Clin. Sci. 136, 1759\u20131772 (2022).","journal-title":"Clin. Sci."},{"key":"1067_CR188","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.celrep.2014.03.064","volume":"7","author":"P Outeda","year":"2014","unstructured":"Outeda, P. et al. Polycystin signaling is required for directed endothelial cell migration and lymphatic development. Cell Rep. 7, 634\u2013644 (2014).","journal-title":"Cell Rep."},{"key":"1067_CR189","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1681\/ASN.2014090856","volume":"27","author":"JL Huang","year":"2016","unstructured":"Huang, J. L. et al. Vascular endothelial growth factor C for polycystic kidney diseases. J. Am. Soc. Nephrol. 27, 69\u201377 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1067_CR190","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ki.2008.661","volume":"75","author":"I Sakamoto","year":"2009","unstructured":"Sakamoto, I. et al. Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int. 75, 828\u2013838 (2009).","journal-title":"Kidney Int."},{"key":"1067_CR191","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1267\/ahc.13006","volume":"46","author":"T Uchiyama","year":"2013","unstructured":"Uchiyama, T., Takata, S., Ishikawa, H. & Sawa, Y. Altered dynamics in the renal lymphatic circulation of type 1 and type 2 diabetic mice. Acta Histochem. Cytochem. 46, 97\u2013104 (2013).","journal-title":"Acta Histochem. Cytochem."},{"key":"1067_CR192","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/01.ASN.0000113316.52371.2E","volume":"15","author":"D Kerjaschki","year":"2004","unstructured":"Kerjaschki, D. et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 15, 603\u2013612 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1067_CR193","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1600-6143.2006.01638.x","volume":"7","author":"S Stuht","year":"2007","unstructured":"Stuht, S. et al. Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol abiopsies. Am. J. Transplant. 7, 377\u2013384 (2007).","journal-title":"Am. J. Transplant."},{"key":"1067_CR194","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.796260","volume":"12","author":"J Lin","year":"2021","unstructured":"Lin, J. et al. Lymphatic reconstruction in kidney allograft aggravates chronic rejection by promoting alloantigen presentation. Front. Immunol. 12, 796260 (2021).","journal-title":"Front. Immunol."},{"key":"1067_CR195","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1124\/pharmrev.123.000938","volume":"76","author":"KT Babalola","year":"2024","unstructured":"Babalola, K. T. et al. Leveraging lymphatic system targeting in systemic lupus erythematosus for improved clinical outcomes. Pharmacol. Rev. 76, 228\u2013250 (2024).","journal-title":"Pharmacol. Rev."},{"key":"1067_CR196","doi-asserted-by":"publisher","DOI":"10.1172\/JCI168412","volume":"135","author":"MJ Howlader","year":"2025","unstructured":"Howlader, M. J. et al. Lymphatic dysfunction in lupus contributes to cutaneous photosensitivity and lymph node B cell responses. J. Clin. Invest. 135, e168412 (2025).","journal-title":"J. Clin. Invest."},{"key":"1067_CR197","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.ajpath.2020.07.015","volume":"190","author":"SE Dorraji","year":"2020","unstructured":"Dorraji, S. E. et al. Kidney tertiary lymphoid structures in lupus nephritis develop into large interconnected networks and resemble lymph nodes in gene signature. Am. J. Pathol. 190, 2203\u20132225 (2020).","journal-title":"Am. J. Pathol."},{"key":"1067_CR198","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00467-022-05770-4","volume":"38","author":"T Yoshikawa","year":"2023","unstructured":"Yoshikawa, T., Lee, Y. H., Sato, Y. & Yanagita, M. Tertiary lymphoid tissues in kidney diseases: a perspective for the pediatric nephrologist. Pediatr. Nephrol. 38, 1399\u20131409 (2023).","journal-title":"Pediatr. Nephrol."},{"key":"1067_CR199","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1204777","volume":"14","author":"M Wang","year":"2023","unstructured":"Wang, M. et al. Tertiary lymphoid structures as local perpetuators of organ-specific immune injury: implication for lupus nephritis. Front. Immunol. 14, 1204777 (2023).","journal-title":"Front. Immunol."},{"key":"1067_CR200","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1681\/ASN.0000000000000488","volume":"36","author":"Y Huang","year":"2025","unstructured":"Huang, Y. et al. Glycolysis in peritubular endothelial cells and microvascular rarefaction in CKD. J. Am. Soc. Nephrol. 36, 19\u201333 (2025).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1067_CR201","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176207","volume":"135","author":"R Tiwari","year":"2024","unstructured":"Tiwari, R. et al. Postischemic inactivation of HIF prolyl hydroxylases in endothelium promotes maladaptive kidney repair by inducing glycolysis. J. Clin. Invest. 135, e176207 (2024).","journal-title":"J. Clin. Invest."},{"key":"1067_CR202","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.amjmed.2008.11.025","volume":"122","author":"F Gurevich","year":"2009","unstructured":"Gurevich, F. & Perazella, M. A. Renal effects of anti-angiogenesis therapy: update for the internist. Am. J. Med. 122, 322\u2013328 (2009).","journal-title":"Am. J. Med."},{"key":"1067_CR203","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.7150\/ijms.114382","volume":"22","author":"D Zha","year":"2025","unstructured":"Zha, D., Gao, P. & Wu, X. Role of metabolic abnormalities during the progression of chronic kidney disease and preventive strategies. Int. J. Med. Sci. 22, 3543\u20133555 (2025).","journal-title":"Int. J. Med. Sci."},{"key":"1067_CR204","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0002-9440(10)61731-2","volume":"159","author":"Y Masuda","year":"2001","unstructured":"Masuda, Y. et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am. J. Pathol. 159, 599\u2013608 (2001).","journal-title":"Am. J. Pathol."},{"key":"1067_CR205","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/s41401-023-01070-1","volume":"44","author":"MJ Huang","year":"2023","unstructured":"Huang, M. J. et al. Targeted VEGFA therapy in regulating early acute kidney injury and late fibrosis. Acta Pharmacol. Sin. 44, 1815\u20131825 (2023).","journal-title":"Acta Pharmacol. Sin."},{"key":"1067_CR206","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1681\/ASN.2006010064","volume":"17","author":"SH Sung","year":"2006","unstructured":"Sung, S. H. et al. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J. Am. Soc. Nephrol. 17, 3093\u20133104 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1067_CR207","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/MNH.0000000000000256","volume":"25","author":"OC Logue","year":"2016","unstructured":"Logue, O. C., McGowan, J. W., George, E. M. & Bidwell, G. L. 3rd Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease. Curr. Opin. Nephrol. Hypertens. 25, 404\u2013409 (2016).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"1067_CR208","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41581-020-0260-2","volume":"16","author":"K Tanabe","year":"2020","unstructured":"Tanabe, K., Wada, J. & Sato, Y. Targeting angiogenesis and lymphangiogenesis in kidney disease. Nat. Rev. Nephrol. 16, 289\u2013303 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"1067_CR209","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/cvr\/cvp093","volume":"83","author":"AH Salmon","year":"2009","unstructured":"Salmon, A. H. et al. Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx. Cardiovasc. Res. 83, 24\u201333 (2009).","journal-title":"Cardiovasc. Res."},{"key":"1067_CR210","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1681\/ASN.2012010017","volume":"23","author":"AH Salmon","year":"2012","unstructured":"Salmon, A. H. et al. Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction. J. Am. Soc. Nephrol. 23, 1339\u20131350 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1067_CR211","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/13860291241306568","volume":"89","author":"L Hana","year":"2025","unstructured":"Hana, L. et al. Prevention of ischemia-reperfusion injury on the porcine model of supra-renal aortic clamp by sulodexide. Clin. Hemorheol. Microcirc. 89, 260\u2013269 (2025).","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"1067_CR212","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1007\/s00125-010-1910-x","volume":"53","author":"LN Broekhuizen","year":"2010","unstructured":"Broekhuizen, L. N. et al. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia 53, 2646\u20132655 (2010).","journal-title":"Diabetologia"},{"key":"1067_CR213","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091772","volume":"12","author":"N Piko","year":"2023","unstructured":"Piko, N., Bevc, S., Hojs, R. & Ekart, R. The role of oxidative stress in kidney injury. Antioxidants 12, 1772 (2023).","journal-title":"Antioxidants"},{"key":"1067_CR214","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1440-1681.2007.04810.x","volume":"35","author":"O Sehirli","year":"2008","unstructured":"Sehirli, O. et al. \u03b1-Lipoic acid protects against renal ischaemia-reperfusion injury in rats. Clin. Exp. Pharmacol. Physiol. 35, 249\u2013255 (2008).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"1067_CR215","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14501","volume":"8","author":"EL Dent","year":"2020","unstructured":"Dent, E. L., Taylor, E. B., Turbeville, H. R. & Ryan, M. J. Curcumin attenuates autoimmunity and renal injury in an experimental model of systemic lupus erythematosus. Physiol. Rep. 8, e14501 (2020).","journal-title":"Physiol. Rep."},{"key":"1067_CR216","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1093\/ndt\/gfn090","volume":"23","author":"J Luo","year":"2008","unstructured":"Luo, J. et al. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol. Dial. Transpl. 23, 2198\u20132205 (2008).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1067_CR217","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9109473","volume":"2019","author":"V Liakopoulos","year":"2019","unstructured":"Liakopoulos, V., Roumeliotis, S., Bozikas, A., Eleftheriadis, T. & Dounousi, E. Antioxidant supplementation in renal replacement therapy patients: is there evidence. Oxid. Med. Cell Longev. 2019, 9109473 (2019).","journal-title":"Oxid. Med. Cell Longev."},{"key":"1067_CR218","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1053\/j.ajkd.2012.06.005","volume":"60","author":"MK Fallahzadeh","year":"2012","unstructured":"Fallahzadeh, M. K. et al. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial. Am. J. Kidney Dis. 60, 896\u2013903 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"1067_CR219","volume":"11","author":"JM Colombijn","year":"2023","unstructured":"Colombijn, J. M. et al. Antioxidants for adults with chronic kidney disease. Cochrane Database Syst. Rev. 11, Cd008176 (2023).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1067_CR220","doi-asserted-by":"publisher","first-page":"i47","DOI":"10.1093\/ndt\/gfae216","volume":"40","author":"M Nardone","year":"2025","unstructured":"Nardone, M. et al. Upcoming drug targets for kidney protective effects in chronic kidney disease. Nephrol. Dial. Transpl. 40, i47\u2013i58 (2025).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1067_CR221","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/S0140-6736(19)30772-X","volume":"393","author":"HJL Heerspink","year":"2019","unstructured":"Heerspink, H. J. L. et al. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Lancet 393, 1937\u20131947 (2019).","journal-title":"Lancet"},{"key":"1067_CR222","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/S0140-6736(23)02230-4","volume":"402","author":"HJL Heerspink","year":"2023","unstructured":"Heerspink, H. J. L. et al. Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial. Lancet 402, 2004\u20132017 (2023).","journal-title":"Lancet"},{"key":"1067_CR223","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22116044","volume":"22","author":"X Li","year":"2021","unstructured":"Li, X. et al. Sodium glucose co-transporter 2 inhibitors ameliorate endothelium barrier dysfunction induced by cyclic stretch through inhibition of reactive oxygen species. Int. J. Mol. Sci. 22, 6044 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1067_CR224","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23420-4","volume":"8","author":"SJ Mancini","year":"2018","unstructured":"Mancini, S. J. et al. Canagliflozin inhibits interleukin-1\u03b2-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms. Sci. Rep. 8, 5276 (2018).","journal-title":"Sci. Rep."},{"key":"1067_CR225","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic, V. et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N. Engl. J. Med. 380, 2295\u20132306 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1067_CR226","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2025-001568","volume":"12","author":"DA Russell","year":"2025","unstructured":"Russell, D. A. et al. Lupus nephritis serum induces changes in gene expression in human glomerular endothelial cells, which is modulated by L-sepiapterin: implications for redox-mediated endothelial dysfunction. Lupus Sci. Med. 12, e001568 (2025).","journal-title":"Lupus Sci. Med."},{"key":"1067_CR227","doi-asserted-by":"publisher","first-page":"F465","DOI":"10.1152\/ajprenal.00036.2023","volume":"325","author":"NC Finch","year":"2023","unstructured":"Finch, N. C., Neal, C. R., Welsh, G. I., Foster, R. R. & Satchell, S. C. The unique structural and functional characteristics of glomerular endothelial cell fenestrations and their potential as a therapeutic target in kidney disease. Am. J. Physiol. Ren. Physiol 325, F465\u2013F478 (2023).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1067_CR228","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1436-1","volume":"10","author":"SD Hwang","year":"2019","unstructured":"Hwang, S. D. et al. Inhibition of lymphatic proliferation by the selective VEGFR-3 inhibitor SAR131675 ameliorates diabetic nephropathy in db\/db mice. Cell Death Dis. 10, 219 (2019).","journal-title":"Cell Death Dis."},{"key":"1067_CR229","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204626","volume":"10","author":"K Zhang","year":"2023","unstructured":"Zhang, K. et al. Renal endothelial cell-targeted extracellular vesicles protect the kidney from ischemic injury. Adv. Sci. 10, e2204626 (2023).","journal-title":"Adv. Sci."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01067-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01067-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01067-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:01:49Z","timestamp":1779451309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01067-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":229,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1038\/s41581-026-01067-z","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"18 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}